Christoph Grander
Innsbruck, 6020, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Revised 16S rRNA V4 hypervariable region targeting primers enhance detection of Patescibacteria and other lineages across diverse environments.
Journal: ISME communications
Published: December 01, 2025
Hepatic Expression of ACBP Is a Prognostic Marker for Weight Loss After Bariatric Surgery.
Journal: Biomolecules
Published: July 14, 2025
Metabolic stress sensing by epithelial RXRα links westernization of diet with Crohn's disease.
Journal: Cell metabolism
Published: February 03, 2025
The pathophysiology of MASLD: an immunometabolic perspective.
Journal: Expert review of clinical immunology
Published: December 27, 2023
Apelin and the gut microbiome: Potential interaction in human MASLD.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 01, 2023
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Journal: Hepatology communications
Published: February 21, 2023
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link.
Journal: Journal of clinical and translational hepatology
Published: February 18, 2023
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
Journal: JHEP reports : innovation in hepatology
Published: December 13, 2022
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options.
Journal: Cardiovascular research
Published: September 28, 2022
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.
Journal: Therapeutic advances in endocrinology and metabolism
Published: July 10, 2022
Last Updated: 09/26/2026